Singapore, 1 August — Warburg Pincus, a leading global growth investor, and Lendlease, an integrated Australian real estate group with international investment capabilities, today announced that they have reached the final closing on a life sciences real estate joint venture platform.
With over 30 years of experience in life sciences real estate, Lendlease has successfully delivered first-class pharmaceutical, biotechnology, and life sciences facilities across the US, APAC, and Europe. Its project construction management business is one of the most well regarded globally, trusted by over life sciences and pharmaceutical companies.
Warburg Pincus has been investing in Asia real estate companies and platforms for nearly 20 years. We are excited to partner with Lendlease, which shares our conviction in the industry, and believe that our in-depth expertise and extensive network and resources in the real estate and healthcare sectors will help the joint venture accelerate its growth and create value for its stakeholders.
Warburg Pincus LLC is a leading global growth investor. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. For more information, please visit www. Lendlease is an integrated real estate group with international investment capabilities. Headquartered in Sydney, Australia, and listed on the Australian Securities Exchange, Lendlease's core capabilities are reflected in its operating segments of Investments, Development, and Construction.
The combination of these three segments provides the Company with a sustainable competitive advantage in delivering innovative integrated solutions for its customers. Back To News.
